Quest Diagnostics (DGX)

EBITDA Growth

7.72%

TTM · Period ending:

DGX logo

DGX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported7.72%
DGX TTM EBITDA YoY % (128.15% → 7.72%)
High-resolution chart · PNG

DGX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Quest Diagnostics EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
14.0095%
25.8321%
56.8723%
86.152%
128.9717%
137.2303%
88.4854%
48.8192%
27.8694%
8.7726%
4.6277%
8.1511%
144.5614%
128.1488%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.